Theravance Biopharma (TBPH) EBT Margin (2013 - 2026)
Theravance Biopharma (TBPH) reported EBT Margin of -23.11% for Q2 2026, down 302.58 percentage points from 279.47% a year earlier but up 13.45 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) EBT Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Theravance Biopharma's EBT Margin came in at 56.48%, up 4.57 percentage points year-over-year; for FY2025, it was 120.27%, up 189.57 percentage points from FY2024.
- EBT Margin has increased for four consecutive years, with a five-year change of +542.42 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -69.30% in FY2024 (+16.50 pp), -85.80% in FY2023 (+94.97 pp), -180.76% in FY2022 (+298.75 pp) and -479.51% in FY2021 (-57.36 pp).
- Five-year quarterly EBT Margin spans a low of -423.81% in Q3 2021 and a high of 279.47% in Q2 2025.
- Year over year, EBT Margin gained in four of the last eight quarters, with an average year-over-year change of +42.56 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2025 (a gain of 386.23 percentage points); the low point was Q2 2026 (a drop of 302.58 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -36.56% (Q1 2026), 159.22% (Q4 2025) and -14.45% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -23.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.11% |
| Mar 31, 2026 | -36.56% |
| Dec 31, 2025 | 159.22% |
| Sep 30, 2025 | -14.45% |
| Jun 30, 2025 | 279.47% |
| Mar 31, 2025 | -91.88% |
| Dec 31, 2024 | -47.66% |
| Sep 30, 2024 | -59.59% |
| Jun 30, 2024 | -106.77% |
| Mar 31, 2024 | -71.72% |
| Dec 31, 2023 | -28.56% |
| Sep 30, 2023 | -48.32% |
| Jun 30, 2023 | -103.19% |
| Mar 31, 2023 | -215.83% |
| Dec 31, 2022 | -97.34% |
| Sep 30, 2022 | -128.69% |
| Jun 30, 2022 | -206.32% |
| Mar 31, 2022 | -301.11% |
| Dec 31, 2021 | -387.84% |
| Sep 30, 2021 | -423.81% |
API Access
Theravance Biopharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();